Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

E-ISSN： 1874-4729|4|4|306-320

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.4, Iss.4, 2011-10, pp. : 306-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 154-155

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 283-294

Bentham Science Publishers

Access to resources Recommend Favorite

Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy

Current Pharmaceutical Design, Vol. 6, Iss. 14, 2000-09 ,pp. : 1433-1455

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Alpha-Particle Therapy with 227Th-Labeled Antibodies

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite